BRAIDWELL LP

Position in NBIX — Neurocrine Biosciences Inc

CIK 1920938 STAMFORD, CT

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$85,910,420

-$20,679,647 QoQ

Shares Held

652,121

-13.2% QoQ

Ownership

0.649%

of shares outstanding

% of Portfolio

3.27%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BRAIDWELL LP holds $138,308,361 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (62.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc This page	652,121	$85,910,420
2	BIOA	BioAge Labs, Inc.	1,200,587	$20,998,266
3	KNSA	Kiniksa Pharmaceuticals International, plc	272,522	$13,121,934
4	EOLS	Evolus, Inc.	3,105,209	$12,762,408
5	HROW	Harrow, Inc.	156,419	$5,515,333

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$85,910,420	652,121	-13.2%	Shares	Sole	2026-05-15
2025-12-31	$106,590,067	751,534	-14.6%	Shares	Sole	2026-02-17
2025-09-30	$123,573,987	880,282	-24.1%	Shares	Sole	2025-11-14
2025-06-30	$145,853,818	1,160,425	-2.6%	Shares	Sole	2025-08-14
2025-03-31	$131,826,905	1,191,925	+32.2%	Shares	Sole	2025-05-15
2024-12-31	$123,094,335	901,790	-1.7%	Shares	Sole	2025-02-14
2024-09-30	$105,734,398	917,674	+20.9%	Shares	Sole	2024-11-14
2024-06-30	$104,492,769	759,009	+3.9%	Shares	Sole	2024-08-14
2024-03-31	$100,710,425	730,209	+2.1%	Shares	Sole	2024-05-15
2023-12-31	$94,235,937	715,209	-26.1%	Shares	Sole	2024-02-14
2023-09-30	$108,902,700	968,024	+3.7%	Shares	Sole	2023-11-14
2023-06-30	$88,016,036	933,362	+21.7%	Shares	Sole	2023-08-14
2023-03-31	$77,615,496	766,800	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.